EPCAM and neoplasm: It is a hybrid rat–mouse mAb with an epithelial cellular adhesion molecule (EpCAM) binding arm (mouse IgG2a) and a CD3 binding arm (rat IgG2b), enabling it to simultaneously bind to EpCAM on tumor cells and CD3 on T cells.